News Release
View printer-friendly version « Back
CONMED to Present at UBS Global Life Sciences Conference
UTICA, N.Y., Sep 22, 2004 /PRNewswire-FirstCall via COMTEX/ -- CONMED Corporation (Nasdaq: CNMD) announced today that the Company will present at the UBS Global Life Sciences Conference on September 28, 2004 at 3:00 PM Eastern time. The event is being held at The Grand Hyatt in New York.
Mr. Joseph J. Corasanti, President and Chief Operating Officer of CONMED, will discuss the Company's business. The live webcast of CONMED's presentation will be available at http://www.conmed.com in the Investor Relations - Events Calendar section of the website.
CONMED Profile
CONMED is a medical technology company specializing in instruments, implants, and video equipment for arthroscopic sports medicine, and powered surgical instruments, such as drills and saws, for orthopedic, ENT, neuro- surgery, and other surgical specialties. The Company is also a leading developer, manufacturer and supplier of RF electrosurgery systems used routinely to cut and cauterize tissue in nearly all types of surgical procedures worldwide, endosurgery products such as trocars, clip appliers, scissors, and surgical staplers. The Company offers integrated operating room design and intensive care unit service managers. The Company also manufactures and sells a full line of ECG electrodes for heart monitoring and other patient care products. Headquartered in Utica, New York, the Company's 2,600 employees distribute its products worldwide from eleven manufacturing locations.
SOURCE CONMED Corporation
Robert Shallish, Chief Financial Officer of CONMED Corporation, +1-315-624-3206; Investors: Julie Huang, Media: Sean Leous, both of Financial Dynamics, +1-212-850-5600, for CONMED Corporation
http://www.conmed.com